Filing Details

Accession Number:
0001079973-21-000713
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-06 19:57:25
Reporting Period:
2021-01-12
Accepted Time:
2021-08-06 19:57:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1128189 Protokinetix Inc. PKTX Pharmaceutical Preparations (2834) 943355026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516077 Edward Clarence Smith 1845 County Road #214
St. Augustine FL 32084
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-12 142,857 $0.07 29,161,110 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-08-04 5,000,000 $0.00 5,000,000 $0.14
Common Stock Stock Option Disposition 2021-08-04 5,000,000 $0.00 5,000,000 $0.14
Common Stock Stock Option Disposition 2021-08-04 5,000,000 $0.00 5,000,000 $0.11
Common Stock Stock Option Disposition 2021-08-04 5,000,000 $0.00 5,000,000 $0.26
Common Stock Stock Option Disposition 2021-08-04 5,000,000 $0.00 5,000,000 $0.09
Common Stock Warrant Acquisiton 2021-01-12 142,857 $0.07 142,857 $0.07
Common Stock Stock Option Acquisiton 2021-08-04 25,000,000 $0.00 25,000,000 $0.11
Common Stock Stock Option Acquisiton 2021-08-04 2,600,000 $0.00 2,600,000 $0.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-03-25 No 4 D Direct
0 2026-03-25 No 4 D Direct
0 2024-11-17 No 4 D Direct
0 2024-07-14 No 4 D Direct
0 2023-11-08 No 4 D Direct
142,857 2021-01-12 2022-01-12 No 4 P Direct
25,000,000 2028-08-03 No 4 A Direct
2,600,000 2028-08-03 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,235,160 Indirect See footnote
Common Stock 1,850,000 Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant $0.12 2019-12-19 2022-12-18 216,666 216,666 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-12-18 216,666 216,666 Direct
Footnotes
  1. Shares purchased in a private placement from the Company.
  2. Shares held by the Clarence E. Smith Trusts.
  3. Shares held by Mr. Smith's retirement account.
  4. Cancelation of options for no value received.
  5. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. Fully vested.
  6. Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. On September 30, 2021, 650,000 shares vest; thereafter 650,000 shares vest each quarter.